ESC 365 - Effects of atrial fibrillation ablation in patients with lV dysfunction: the CASTE-AF trial.

Open Access

Effects of atrial fibrillation ablation in patients with lV dysfunction: the CASTE-AF trial.

Session: Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?

Topic: Outcomes and Complications

Speaker: Professor J. Brachmann (Coburg, DE)

Event: ESC Congress 2018

Congress Session

About the speaker

Professor Johannes Brachmann

REGIOMED Clinics Coburg, Coburg (Germany)

8 presentations

0 follower

3 more presentations in this session

Effects of atrial fibrillation ablation in patients with stroke risk factors: the CABANA Trial.

Speaker: Doctor D. Packer (Rochester, US)

Critical appraisal of the CABANA and CASTLE-AF trials.

Speaker: Professor I. Van Gelder (Groningen, NL)

Will the technical improvements in atrial fibrillation ablation further improve the success of atrial fibrillation ablation.

Speaker: Professor G. Hindricks (Leipzig, DE)

Access the full session

Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?

Speakers: Professor J. Brachmann, Doctor D. Packer, Professor I. Van Gelder, Professor G. Hindricks

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

This platform is supported by